EA201401341A1 - Твердые формы n-((s)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида - Google Patents

Твердые формы n-((s)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида

Info

Publication number
EA201401341A1
EA201401341A1 EA201401341A EA201401341A EA201401341A1 EA 201401341 A1 EA201401341 A1 EA 201401341A1 EA 201401341 A EA201401341 A EA 201401341A EA 201401341 A EA201401341 A EA 201401341A EA 201401341 A1 EA201401341 A1 EA 201401341A1
Authority
EA
Eurasian Patent Office
Prior art keywords
iodophenylamino
isonicotinamide
fluoro
solid forms
dihydroxipropyl
Prior art date
Application number
EA201401341A
Other languages
English (en)
Other versions
EA028059B1 (ru
Inventor
Аксель Беккер
Кристоф Заль
Клеменс Кюн
Доналд Бенкстон
Марко Пома
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201401341A1 publication Critical patent/EA201401341A1/ru
Publication of EA028059B1 publication Critical patent/EA028059B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)

Abstract

Изобретение относится к твердым формам N-((S)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида, способам их получения и их медицинским применениям.
EA201401341A 2012-05-30 2013-05-07 Твердые формы n-((s)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида EA028059B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261653037P 2012-05-30 2012-05-30
PCT/EP2013/001352 WO2013178320A1 (en) 2012-05-30 2013-05-07 Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide

Publications (2)

Publication Number Publication Date
EA201401341A1 true EA201401341A1 (ru) 2015-05-29
EA028059B1 EA028059B1 (ru) 2017-10-31

Family

ID=48537929

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201401341A EA028059B1 (ru) 2012-05-30 2013-05-07 Твердые формы n-((s)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида

Country Status (30)

Country Link
US (1) US9260393B2 (ru)
EP (1) EP2855434B1 (ru)
JP (1) JP6280543B2 (ru)
KR (1) KR20150022923A (ru)
CN (1) CN104334530A (ru)
AR (1) AR091186A1 (ru)
AU (1) AU2013269994B2 (ru)
BR (1) BR112014029838A2 (ru)
CA (1) CA2875145C (ru)
CL (1) CL2014003285A1 (ru)
DK (1) DK2855434T3 (ru)
EA (1) EA028059B1 (ru)
ES (1) ES2592860T3 (ru)
HK (1) HK1206733A1 (ru)
HR (1) HRP20161135T1 (ru)
HU (1) HUE028850T2 (ru)
IL (1) IL235947A (ru)
LT (1) LT2855434T (ru)
MX (1) MX350295B (ru)
MY (1) MY169266A (ru)
NZ (1) NZ701103A (ru)
PL (1) PL2855434T3 (ru)
PT (1) PT2855434T (ru)
RS (1) RS55167B1 (ru)
SG (1) SG11201407842TA (ru)
SI (1) SI2855434T1 (ru)
TW (1) TWI570108B (ru)
UA (1) UA112899C2 (ru)
WO (1) WO2013178320A1 (ru)
ZA (1) ZA201409426B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015127234A1 (en) * 2014-02-20 2015-08-27 Board Of Regents, The University Of Texas System Use of ibrutinib to treat egfr mutant cancer
US10179132B2 (en) 2015-05-26 2019-01-15 Industry-Academic Cooperation Foundation, Yonsei University Composition for inducing differentiation of multipotent neural stem cells into dopaminergic neurons and method for inducing differentiation of multipotent neural stem cells into dopaminergic neurons by using the same
KR20160138756A (ko) * 2015-05-26 2016-12-06 연세대학교 산학협력단 신경줄기세포로부터 도파민 신경세포로의 분화 유도용 조성물 및 이를 이용하여 신경줄기세포로부터 도파민 신경세포로 분화시키는 방법
NZ754020A (en) 2016-11-25 2022-11-25 Genuv Inc Composition for promoting differentiation of and protecting neural stem cells and method for inducing neural regeneration using same
KR101833412B1 (ko) 2017-07-24 2018-02-28 연세대학교 산학협력단 신경줄기세포로부터 도파민 신경세포로의 분화 유도용 조성물 및 이를 이용하여 신경줄기세포로부터 도파민 신경세포로 분화시키는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501277A (en) * 1997-07-01 2002-12-20 Warner Lambert Co -2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
ATE302761T1 (de) * 1999-01-13 2005-09-15 Warner Lambert Co 1-heterozyklus-substituierte diarylaminen
EP1513840B1 (en) * 2002-05-31 2006-10-04 Bayer Pharmaceuticals Corporation Compounds and compositions for the treatment of diabetes and diabetes-related disorders
AR051248A1 (es) 2004-10-20 2007-01-03 Applied Research Systems Derivados de 3-arilamino piridina
CN102134218A (zh) * 2009-06-15 2011-07-27 凯美隆(北京)药业技术有限公司 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂

Also Published As

Publication number Publication date
PT2855434T (pt) 2016-10-04
AU2013269994B2 (en) 2017-04-20
KR20150022923A (ko) 2015-03-04
IL235947A0 (en) 2015-02-01
ES2592860T3 (es) 2016-12-01
TWI570108B (zh) 2017-02-11
EP2855434B1 (en) 2016-06-22
NZ701103A (en) 2016-09-30
TW201400459A (zh) 2014-01-01
JP2015518013A (ja) 2015-06-25
CA2875145C (en) 2021-01-12
SI2855434T1 (sl) 2016-10-28
CN104334530A (zh) 2015-02-04
LT2855434T (lt) 2016-12-12
RS55167B1 (sr) 2017-01-31
SG11201407842TA (en) 2014-12-30
EA028059B1 (ru) 2017-10-31
CL2014003285A1 (es) 2015-03-06
UA112899C2 (uk) 2016-11-10
WO2013178320A1 (en) 2013-12-05
MX350295B (es) 2017-09-04
US9260393B2 (en) 2016-02-16
IL235947A (en) 2016-08-31
MX2014014520A (es) 2015-02-24
BR112014029838A2 (pt) 2017-06-27
HK1206733A1 (en) 2016-01-15
PL2855434T3 (pl) 2016-12-30
EP2855434A1 (en) 2015-04-08
AU2013269994A1 (en) 2015-01-22
ZA201409426B (en) 2017-05-31
US20150152059A1 (en) 2015-06-04
JP6280543B2 (ja) 2018-02-14
AR091186A1 (es) 2015-01-14
DK2855434T3 (en) 2016-09-12
HUE028850T2 (en) 2017-01-30
HRP20161135T1 (hr) 2016-11-04
MY169266A (en) 2019-03-20
CA2875145A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201491996A1 (ru) Антагонисты st2l и способы их применения
EA201491505A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201201016A1 (ru) Антидоты антикоагулянтов
MA34091B1 (fr) Anticorps anti-cd40
EA201300388A1 (ru) Соединения замещенного бензамида
EA201892509A1 (ru) Антитела к гемагглютинину и способы применения
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
EA201491357A1 (ru) Анти-lrp5 антитела и способы их применения
EA201992707A1 (ru) Соединения и их применения для модуляции гемоглобина
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
EA201290642A1 (ru) Соединения и способы
UY34553A (es) Procedimiento de preparación de la sal de l-arginina de perindoprilo
EA201301090A1 (ru) Антидоты антикоагулянтов
EA201401341A1 (ru) Твердые формы n-((s)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба
EA201890347A1 (ru) Антитела и исследования для обнаружения cd37
UA113540C2 (xx) Поліморфи n-(2-метоксибензоїл)-4-$(метиламінокарбоніл)аміно]бензолсульфонаміду
EA201690294A1 (ru) Новые соединения и их применение для получения tau-визуализирующих агентов и tau-визуализирующих составов
BR112015005627A2 (pt) composto, composição farmacêutica, uso de composto, método de tratamento e invenção.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM